Protara Therapeutics, Inc. (TARA)
3.995
+0.08
(+2.17%)
USD |
NASDAQ |
Aug 27, 16:00
3.995
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics EPS Diluted (TTM) : -1.354 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.354 |
| March 31, 2026 | -1.352 |
| December 31, 2025 | -1.336 |
| September 30, 2025 | -1.443 |
| June 30, 2025 | -1.632 |
| March 31, 2025 | -1.726 |
| December 31, 2024 | -2.405 |
| September 30, 2024 | -2.821 |
| June 30, 2024 | -3.188 |
| March 31, 2024 | -3.739 |
| December 31, 2023 | -3.567 |
| September 30, 2023 | -6.126 |
| June 30, 2023 | -5.940 |
| March 31, 2023 | -5.70 |
| December 31, 2022 | -5.856 |
| September 30, 2022 | -3.308 |
| June 30, 2022 | -3.584 |
| March 31, 2022 | -3.958 |
| December 31, 2021 | -4.201 |
| September 30, 2021 | -4.079 |
| June 30, 2021 | -4.380 |
| March 31, 2021 | -4.470 |
| December 31, 2020 | -5.080 |
| September 30, 2020 | -42.64 |
| June 30, 2020 | -78.10 |
| Date | Value |
|---|---|
| March 31, 2020 | -99.22 |
| December 31, 2019 | -120.67 |
| September 30, 2019 | -93.26 |
| June 30, 2019 | -66.66 |
| March 31, 2019 | -55.37 |
| December 31, 2018 | -45.87 |
| September 30, 2018 | -47.53 |
| June 30, 2018 | -80.61 |
| March 31, 2018 | -82.76 |
| December 31, 2017 | -84.60 |
| September 30, 2017 | -88.80 |
| June 30, 2017 | -62.80 |
| March 31, 2017 | -68.80 |
| December 31, 2016 | -69.20 |
| September 30, 2016 | -67.60 |
| June 30, 2016 | -63.60 |
| March 31, 2016 | -56.80 |
| December 31, 2015 | -52.00 |
| September 30, 2015 | -15.44 |
| June 30, 2015 | -22.14 |
| March 31, 2015 | -21.63 |
| December 31, 2014 | -22.02 |
| September 30, 2014 | -53.10 |
| June 30, 2014 | -41.40 |
| March 31, 2014 | -38.51 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| NovelStem International Corp. | -0.0064 |
| Brainstorm Cell Therapeutics, Inc. | -0.9541 |
| Summit Therapeutics, Inc. | -1.119 |
| Kezar Life Sciences, Inc. | -6.176 |
| Clene, Inc. | -3.512 |